CREATE-X
CREATE-X is a Georgia Tech initiative to instill entrepreneurial confidence in students and empower them to launch real startups. The broader goal of this initiative is to provide the knowledge, skills, abilities, and experiences that will give Georgia Tech graduates the confidence to create their own future and confidently pursue entrepreneurial opportunities.
CREATE-X
Industry:
Education Training
Founded:
2014-01-01
Status:
Active
Contact:
404.894.2000
Total Funding:
2.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Nginx
Similar Organizations
CanopyBoulder
CanopyBoulder is a mentorship-driven seed-stage business accelerator and investment fund.
CommercialTribe
CT Connect is software to guide and optimize who sales managers coach, where, and perhaps most importantly how.
Platzi
Platzi is an effective online education platform that offers classes on marketing, programming, business, and design.
Current Advisors List
Board_member
2020-02-01
Current Employees Featured
Rahul Saxena Associate Director @ CREATE-X
Associate Director
2019-02-25
Raghupathy Sivakumar Founder and Director @ CREATE-X
Founder and Director
2014-01-01
Founder
Investors List
The Marcus Foundation
The Marcus Foundation investment in Grant - CREATE-X
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-23 | Mensari | CREATE-X investment in Pre Seed Round - Mensari | N/A |
2022-08-18 | AutoMedTech Inc. | CREATE-X investment in Grant - AutoMedTech Inc. | 5 K USD |
2022-07-29 | Tortoise Charging Inc. | CREATE-X investment in Grant - Tortoise Charging Inc. | 5 K USD |
2022-07-27 | Quivr | CREATE-X investment in Grant - Quivr | N/A |
2022-07-12 | Unifi.ai | CREATE-X investment in Grant - Unifi.ai | 5 K USD |
2022-06-30 | GoodAction | CREATE-X investment in Grant - GoodAction | N/A |
2022-06-30 | SilverMoxie Ventures | CREATE-X investment in Grant - SilverMoxie Ventures | 5 K USD |
2022-05-17 | Haven Now | CREATE-X investment in Pre Seed Round - Haven Now | 5 K USD |
2022-03-06 | DevX Labs, Inc. | CREATE-X investment in Pre Seed Round - DevX Labs, Inc. | N/A |
2021-08-31 | Intrface Solutions | CREATE-X investment in Grant - Intrface Solutions | N/A |
More informations about "CREATE-X"
Home | CREATE-X
CREATE-X is a Georgia Tech initiative to instill entrepreneurial confidence in students and empower them to launch successful startups.See details»
Adjuvant Capecitabine for Breast Cancer after Preoperative …
A complete list of the investigators in the Capecitabine for Residual Cancer as Ad-juvant Therapy (CREATE-X) trial is pro-vided in the Supplementary Appendix, available at NEJM.org.See details»
CREATE-X Releases Report on 10-Year Milestone | CREATE-X
Founded in 2014, CREATE-X has grown from a visionary concept into a transformative program that has empowered more than 34,000 students to launch more than 560 startups, achieving a …See details»
CREATE-X: A Decade of Success | Office of Development
CREATE-X, Georgia Tech’s initiative to promote entrepreneurial confidence in students and empower them to launch successful startups, celebrates 10 years of success this year.See details»
CREATE-X - Crunchbase School Profile & Alumni
CREATE-X is a Georgia Tech initiative and accelerator for students to launch successful startups.See details»
Overview | CREATE-X
MAKE The CREATE-X MAKE element consists of a set of research and prototyping classes that enable students to overcome technology barriers that might lie in the way of them launching a …See details»
CREATE-X MAKE
About The CREATE-X MAKE element consists of a set of research and prototyping programs that enable students to overcome technology barriers that might lie in the way of them launching a …See details»
CREATE-X - prodevs.io
CREATE-X is a Georgia Tech initiative and accelerator designed to help students launch successful startups. The program offers a variety of resources and support to budding …See details»
CREATE-X | Commercialization
The Georgia Institute of Technology ’s CREATE-X Startup Launch, a program for Georgia Tech students and alumni who want to launch their projects from idea stage (or beyond) into fully …See details»
CREATE-X - raizer.app
CREATE-X is a Georgia Tech initiative and accelerator for students to launch successful startups. Learn which startups CREATE-X invests in, number of investmenst, exits, and contact info to …See details»
CREATE-X a role for capecitabine in early-stage breast cancer: an ...
Of the five early-stage breast cancer trials addressing the capecitabine question, only CREATE-X was designed to address a specific single hypothesis (sequential administration of non-cross …See details»
Recent News | CREATE-X
Georgia Tech's CREATE-X program, bolstered by generous philanthropic support, celebrates 10 years of building entrepreneurial confidence in students.See details»
CREATE-X Announces 2025 Jim Pope Fellows | CREATE-X
CREATE-X is pleased to announce the next cohort of faculty members selected for the Jim Pope Fellowship for the upcoming academic year. The program provides faculty fellows with funds …See details»
List of top CREATE-X Portfolio Companies - Crunchbase
CREATE-X is a Georgia Tech initiative and accelerator for students to launch successful startups. This list of organizations invested in by CREATE-X provides data on their funding history, …See details»
CREATE-X (JBCRG-04)|Clinical Trials|Japan Breast Cancer …
CREATE-X (JBCRG-04): A phase III trial of adjuvant capecitabine in breast cancer patients with HER2-negative pathologic residual invasive disease after neoadjuvant chemotherapy …See details»
Six Tips to Begin Your Startup With CREATE-X | CREATE-X
Attend CREATE-X events to get insights into entrepreneurship, workshop business ideas, find teammates, and prepare your Startup Launch applications. For additional questions, email …See details»
CREATE-X a role for capecitabine in early-stage breast cancer: an ...
One randomized clinical trial (CREATE-X) of capecitabine versus no additional therapy has been conducted in women with early stage breast cancer who received standard chemotherapy pre …See details»
CREATE-X a role for capecitabine in early-stage breast cancer: an ...
The CREATE-X trial included patients with both ER-positive and ER-negative breast cancer but used a “functional test” of sorts (response to neoadjuvant chemotherapy) to exclude patients …See details»
Lepodisiran — A Long-Duration Small Interfering RNA Targeting ...
Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting …See details»
How To Build an Organizational Chart - Connecteam
To create an organizational chart, first, gather all the necessary and up-to-date information about your company’s employees, such as names and job titles, departmental divisions, and …See details»